- Home
- RRGB vs MNOV Comparison
RRGB vs MNOV Comparison
Compare RRGB & MNOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RRGB | MNOV |
|---|---|---|
| Founded | 1969 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Restaurants | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 86.8M | 72.7M |
| IPO Year | 2002 | 2004 |
Fundamental Metrics
Financial Performance| Metric | RRGB | MNOV |
|---|---|---|
| Price | $2.60 | $1.38 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 4 |
| Target Price | ★ $9.50 | $7.50 |
| AVG Volume (30 Days) | ★ 458.8K | 63.8K |
| Earning Date | 02-25-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 73.43 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,315,014,000.00 | $2,360,807.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 194.15 |
| 52 Week Low | $2.50 | $1.13 |
| 52 Week High | $7.52 | $1.96 |
Technical Indicators
Market Signals| Indicator | RRGB | MNOV |
|---|---|---|
| Relative Strength Index (RSI) | 25.23 | 44.39 |
| Support Level | N/A | $1.22 |
| Resistance Level | $4.42 | $1.40 |
| Average True Range (ATR) | 0.23 | 0.06 |
| MACD | -0.10 | 0.01 |
| Stochastic Oscillator | 3.62 | 17.64 |
Price Performance
Historical ComparisonAbout RRGB Red Robin Gourmet Burgers Inc.
Red Robin Gourmet Burgers Inc is a restaurant operator. The company develops, operates, and franchises casual-dining restaurants and fast-casual restaurants in North America. Its brands are Red Robin, Red Robin Gourmet Burgers, Red Robin America's Gourmet Burgers and Spirits, Red Robin Burger Works, YUMMM, Red Robin Gourmet Burgers and Brews, and Red Robin Royalty names and logos. The company's revenue consists of sales from restaurant operations, gift card breakage, franchise royalties and fees, and other miscellaneous revenue. The company has one operating and one reportable segment: restaurants.
About MNOV Medicinova Inc
MediciNova Inc is a biopharmaceutical company. The company acquires and develops small-molecule therapeutics for the treatment of diseases with unmet medical needs with a specific focus on the U.S. market. Its products portfolio includes therapeutics such as MN-001, MN-166, MN-221 etc. The firm's strategies are to focus its developing activities on therapeutics for neurological disorders and fibrotic diseases.